Victoria Bartolomei, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 431 Calle Cesar Gonzalez, San Juan, PR 00918 Phone: 787-250-8285 Fax: 787-250-8445 |
Lilia I Rivera, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 239 Ave Arterial Hostos, Capital Center 306, San Juan, PR 00918 Phone: 787-250-1746 Fax: 787-250-1746 |
Dr. Lorna Alexandra Vargas, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 611 Calle Europa Ste 212, San Juan, PR 00909 Phone: 787-728-3399 Fax: 787-726-0600 |
Roberto Buxeda, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 29 Calle Washington, Ste 110, San Juan, PR 00907 Phone: 787-723-0931 Fax: 787-723-0931 |
Dr. Natalio Izquierdo Encarnacion, MD Ophthalmology - Glaucoma Specialist Medicare: Accepting Medicare Assignments Practice Location: 369 De Diego Ave. , Torre San Francisco, Suite 310, San Juan, PR 00923 Phone: 787-767-8872 Fax: 787-282-8342 |
News Archive
Bristol-Myers Squibb Company and the ADAP Crisis Task Force today announced an enhanced agreement to support the efforts of AIDS Drug Assistance Programs to provide antiretroviral medicines to people living with HIV and AIDS. Building on an agreement signed in March of 2010, today's announcement marks a multi-year enhancement to assist ADAPs in meeting the challenges of increasing patient case loads and strained government funding.
Professor John Walker-Smith had been found guilty of professional misconduct following claims he took part in unapproved research that suggested links between the vaccine, bowel disease and autism. Professor Walker-Smith lost his license to practice in May 2010 along with Dr Andrew Wakefield, who led the research. A General Medical Council's ‘fitness to practice' panel found both men guilty of misconduct over the way the work was conducted after 217 days of deliberation – the longest disciplinary case in the body's 150- year history.
A team of researchers, Gloria Petersen, Ph.D., of Mayo Clinic, Barbara Koenig, Ph.D., of the University of California, San Francisco, and Susan Wolf, J.D., of the University of Minnesota, have received a five-year, $2.5 million grant from the National Cancer Institute and the National Human Genome Research Institute to study the ethical and legal implications of providing genetic research results, such as DNA test results, from tissue donated to research bio banks to relatives of the donor.
Shire plc, the global specialty biopharmaceutical company, today announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV(TM) (guanfacine) Extended Release Tablets for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years.
› Verified 2 days ago